[1]谢小娟,朱 娜,潘晶晶,等.miRNA-148a在膀胱癌组织中的表达及生物信息学分析[J].现代检验医学杂志,2015,30(04):6-9.[doi:10.3969/j.issn.1671-7414.2015.04.002]
 XIE Xiao-juan,ZHU Na,PAN Jing-jing,et al.Expression of miRNA-148a in Bladder Carcinoma Tissues and Its Bioinformatics Analysis[J].Journal of Modern Laboratory Medicine,2015,30(04):6-9.[doi:10.3969/j.issn.1671-7414.2015.04.002]
点击复制

miRNA-148a在膀胱癌组织中的表达及生物信息学分析()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年04期
页码:
6-9
栏目:
论著
出版日期:
2015-08-10

文章信息/Info

Title:
Expression of miRNA-148a in Bladder Carcinoma Tissues and Its Bioinformatics Analysis
文章编号:
1671-7414(2015)04-006-05
作者:
谢小娟12朱 娜3潘晶晶2魏力强1陈葳2
1.陕西省临床检验中心,西安 710068;
2.西安交通大学医学院第一附属医院检验科,西安 710061;
3.陕西省人民医院科研处,西安 710068
Author(s):
XIE Xiao-juan12ZHU Na3PAN Jing-jing2WEI Li-qiang1CHEN Wei2
1.Shaanxi Center for Clinical Laboratory,Xi'an 710068,China;
2.Department of Clinical Laboratory,the First Affiliated Hospital,School of Medicine,Xi'an Jiaotong University,Xi'an 710061,China;
3.Scientific Research Division,Shaanxi Provincial
关键词:
膀胱癌 miRNA-148a 生物信息学
分类号:
R737.14; R730.43
DOI:
10.3969/j.issn.1671-7414.2015.04.002
文献标志码:
A
摘要:
目的 探索miRNA-148a在膀胱癌发生发展中的作用。方法 收集35例膀胱癌组织和16例非癌组织,采用荧光定量PCR方法检测miRNA-148a的相对表达量,并分析其与临床特征的相关性; 采用生物信息学分析,预测miRNA-148a的靶基因和转录因子,构建TF-miRNA-148a-靶基因调控网络图,并对其靶基因进行GO富集和KEGG Pathway分析。结果 miRNA-148a在膀胱癌中的相对表达量(0.0008±0.0002)明显低于非癌组织(0.0021±0.0005)(t=2.46,P<0.05),其相对表达量在不同性别、年龄、病理分级、临床分期、淋巴结转移组的差异无统计学意义(P>0.05)。3个软件都预测到的miRNA-148a靶基因268个; 预测到miRNA-148a的转录因子60个,结合评分>80的结合位点657个; 对268个靶基因进行GO富集分析,发现其靶基因主要涉及神经细胞分化、发育、增殖、mRNA合成,蛋白连接等众多的生物学过程(P<0.001,相对于背景具有统计意义); KEGG Pathway分析发现268个靶基因参与p53,恶性肿瘤、前列腺癌、PI3K-AKT等信号通路(P<0.05,相对于背景具有统计意义); 根据构建的TF-miRNA-148a-靶基因调控网络图,挖掘出可能调控miRNA-148a的转录因子有SP1,ESR1,AP1,MYC,BRCA1等; 可能受miRNA-148a调控的基因有IGF1,P27kip1,NCOA1,PTEN,SERPINE1等。结论 miRNA-148a在膀胱癌中表达下调,可能参与膀胱癌的发生发展,生物信息学分析为后续研究提供一定的思路。
Abstract:
Objective To explore the role of miRNA-148a inbladder tumorous development and progression.Methods Expression of miRNA-148a was assessed in 35 bladder carcinoma tissues and 16 non-carcinoma tissues by fluorescence quantitative real time PCR,and correlationwith clinical features was evaluated.Target genes and transcription factors ofmiRNA-148a were predicted using bioinformatic analysis,then TF-miRNA-148a-target genes network diagram was built and the target genes was analyzed of geneontology enrichment and KEGG pathway.Results Expressionof miRNA-148a was lower in bladder carcinoma tissues than in non-carcinoma tissues(0.000 8±0.000 2 vs 0.002 1±0.000 5)(t=2.46,P<0.05),but itsexpression was no statistical significance in different groups of gender,age,pathological classification,clinical stage,lymph node metastasis(P>0.05).268 target genes of miRNA-148a were predicted by three softwares at the sametime,60 transcription factors were predicted and the binding sites with combination scroes above 80 was 657.The target genes of miRNA-148a was enriched in many biological processes,such as neuron differentiation,generation of neurons,neuron projection development,cytoplasmic mRNA processing body,cytoplasm(P<0.001).They also participated in p53 signaling pathway,proteoglycans in cancer-homo sapiens,pathways in cancer,prostate cancer,protein processing inendoplasmic reticulum,focal adhesion and so on(P<0.05).According to TF-miRNA-148a-target genes network diagram,miRNA-148a was regulated by SP1,ESR1,AP1,MYC and BRCA1,genes of IGF1,P27kip1,NCOA1,PTEN,SERPINE1 mightbe regulated by miRNA-148a.Conclusion miRNA-148a which was significantly down-regulation in bladder carcinoma tissues may be participate in bladder tumorous development and progression,bioinformatics analysis provides some ideas for further research.

参考文献/References:

[1] Osman A.MicroRNAs in health and disease-basic science and clinical applications[J].Clin Lab,2012,58(5/6):393-402.
[2] 蒋永容,陈 川,张志敏,等.miRNA-122a靶基因预测及生物信息学分析[J].中国肿瘤临床,2011,38(16):931-934.
Jiang YR,Chen C,Zhang ZM,et al.Bioinformatic analysis and prediction of miRNA-122a target genes[J].Chinese Journal of Clinical Oncology,2011,38(16):931-934.
[3] Chiyomaru T,Enokida H,Tatarano S,et al.miRNA-145 and miRNA-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer[J].Br J Cancer,2010,102(5):883-891.
[4] Lin T,Dong W,Huang J,et al.MicroRNA-143 as a tumor suppressor for bladder cancer[J].J Urol,2009,181(3):1372-1380.
[5] Ichimi T,Enokida H,Okuno Y,et al.Identification of novel microRNA targets based on microRNA signatures in bladder cancer[J].International Journalof Cancer,2009,125(2):345-352.
[6] Baffa R,Fassan M,Volinia S,et al.MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets[J].J Pathol,2009,219(2):214-221.
[7] Wang Y,Luo HM,Li Y,et al.hsa-miRNA-96 up-regulates MAP4K1 and IRS1and may function as a promising diagnostic marker in human bladder urothelial carcinomas[J].Molecular Medicine Reports,2012,5(1):260-265.
[8] Song YX,Yue ZY,Wang ZN,et al.MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation[J].Mol Cancer,2011(10):1.
[9] Zhang H,Li Y,Huang Q,et al.MiRNA-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer[J].Cell Death Differ,2011,18(11):1702-1710.
[10] Hummel R,Hussey DJ,Michael MZ,et al.MiRNAs and their association with locoregional staging and survival following surgery foresophageal carcinoma[J].Ann Surg Oncol,2011,18(1):253-260.
[11] Hanoun N,Delpu Y,Suriawinata AA,et al.The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis[J].Clin Chem,2010,56(7):1107-1118.
[12] Zhu AK,Xia JZ,Zuo JB,et al.MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer[J].Med Oncol,2012,29(4):2701-2709.
[13] Fujita Y,Kojima K,Ohhashi R,et al.miR-1480 Attenuates paclitaxel resistance of hormone-refractory,drug-resistant prostate cancer PC3 cells by regulating MSK1 expression[J].J Biol Chen,2010,285(25):19076-19084.
[14] 邓 震,矫 力,蔡小兵,等.microRNA-148a对前列腺癌细胞系LNCaP神经内分泌分化的影响[J].上海医学,2011,34(7):500-503.
Deng Z,Jiao L,Cai XB,et al.Effect of microRNA-148a on neuroendocrinedifferentiation of human prostate cancer cell line LNCaP[J].Shanghai Med J,2011,34(7):500-503.
[15] Yuan K,Lian ZR,Sun B,et al.Role of miRNA-148a in hepatitis B associated hepatocellular carcinoma[J].PLos One,2012,7(4):e35331.
[16] Guo SL,Peng Z,Yang X,et al.miRNA-148a promoted cell proliferation by targeting p27 in gastric cancer cells[J].International Journal of Biological Sciences,2011,7(5):567-574.
[17] Koss LG. Bladder cancer from a perspective of 40 years[J].J Cell Biochem Suppl,1992,161:23-29.
[18] Wu XR.Urothelial tumorigenesis:a tale of divergent pathways[J].NatRev Cancer,2005,5(9):713-725.

相似文献/References:

[1]陈健康,彭道荣,陈慧昱,等.尿液膀胱肿瘤抗原水平检测在膀胱癌诊断中的意义[J].现代检验医学杂志,2019,34(06):135.[doi:10.3969 / j.issn.1671-7414.2019.06.034]
 CHEN Jian-kang,PENG Dao-rong,CHEN Hui-yu,et al.Significance of Urine Bladder Tumor Antigen Level in the Diagnosis of Bladder Cancer[J].Journal of Modern Laboratory Medicine,2019,34(04):135.[doi:10.3969 / j.issn.1671-7414.2019.06.034]
[2]郎海雷,曹雷涛,贵英斌,等.LncRNA NNT-AS1 通过调控miR-582-5p/NCKAP1 轴激活Hippo-YAP/TAZ 信号通路促进膀胱癌细胞增殖、迁移、侵袭和干细胞干性影响[J].现代检验医学杂志,2023,38(04):27.[doi:10.3969/j.issn.1671-7414.2023.04.005]
 LANG Hailei,CAO Leitao,GUI Yingbin,et al.LncRNA NNT-AS1 Activates Hippo-YAP/TAZ Signaling Pathway by Regulating miR-582-5p/NCKAP1 Axis to Promote Bladder Cancer Cell Proliferation, Migration, Invasion and Stem Cell Stemness Effects[J].Journal of Modern Laboratory Medicine,2023,38(04):27.[doi:10.3969/j.issn.1671-7414.2023.04.005]
[3]梅 竹,任 赛,唐思恬,等.膀胱癌患者尿液外泌体中miR-494-3p,LncRNA MAGI2-AS3 表达水平及临床价值研究[J].现代检验医学杂志,2024,39(04):5.[doi:10.3969/j.issn.1671-7414.2024.04.002]
 MEI Zhu,REN Sai,TANG Sitian,et al.Study on Expression Levels and Clinical Value of miR-494-3p and LncRNA MAGI2-AS3 in Urine Exosomes of Patients with Bladder Cancer[J].Journal of Modern Laboratory Medicine,2024,39(04):5.[doi:10.3969/j.issn.1671-7414.2024.04.002]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金面上项目(81372151)。
作者简介:谢小娟(1981-),女,硕士,主要从事分子生物学研究。
通讯作者:陈 葳(1962-),女,博士生导师,E-mail:chenwei808@mail.xjtu.edu.cn。
更新日期/Last Update: 2015-08-10